The mean serum IgA was 38% higher in patients with axSpA compared to controls.7 The increase in IgA levels was associated with systemic inflammation, especially subclinical gut inflammation, suggesting a link between mucosal immune activation and the pathogenesis.7 There have only been 10 reported cases of axSpA associated with IgAV. The gene discussed is CD79A; the disease is inflammation.